Brenntag SE

2021 — FY 2021 (reported Mar 2022)

Brenntag reported record FY‑2021 results: sales approximately EUR 14.38 bn; operating gross profit approximately EUR 3.379 bn (+19.6% fx‑adj); operating EBITDA approximately EUR 1.345 bn (+29.5%); EPS EUR 2.90 [1], [2], [3].

The market viewed Brenntag as a resilient growth story that successfully converted strong commodity pricing and supply‑chain dislocations into outsized gross‑profit and margin expansion. Investor focus shifted to execution and scale of the two‑division setup (Essentials / Specialties) [1], [2], [3].

A clear rally and uptrend ran through 2021 into early 2022, driven by earnings surprises and margin expansion [4].

Q1 2022 (reported May 2022)

Q1/2022 delivered the best quarter on record at the time: operating gross profit approximately EUR 1,038 m (+30.8%) and operating EBITDA approximately EUR 463 m (+48.8%); both divisions contributed strongly [11].

Confidence peaked as investors priced in continued outperformance and validated the decision to split into Essentials and Specialties. Sentiment favored high growth and operational leverage.

Technical action showed a short‑term breakout and continuation of the 2021–early‑2022 uptrend as fundamentals surprised to the upside [11].

FY 2022 (reported Mar 2023)

Record FY‑2022 results: sales approximately EUR 19.43 bn; operating gross profit approximately EUR 4.319 bn; operating EBITDA approximately EUR 1.809 bn; EPS EUR 5.74. Management announced the "Strategy to Win", reported Project Brenntag delivered ahead of plan (additional recurring op. EBITDA approximately EUR 249 m vs. 2019 baseline), proposed dividend increase and a first‑ever share buyback program up to EUR 750 m [9], [12].

The narrative shifted from cyclical beneficiary to validated transformation and shareholder‑value story. Strong cash generation combined with explicit buyback and dividend moves pushed perception toward a higher‑quality compounder with activist‑style capital allocation.

The stock entered a parabolic run to cyclical peak with valuation re‑rating; later signs of topping emerged as investors began to factor normalization of volumes and margins despite cash returns [9].

2023 — FY 2023 & strategic reset (reported Mar 2024)

The group delivered the second‑best year: operating gross profit approximately EUR 4.0418 bn (‑3.7% vs 2022) and operating EBITA approximately EUR 1,265 m (‑13.1%); record free cash flow approximately EUR 1,712 m. The company completed substantial M&A (eight deals, total EV approximately EUR 570 m) and advanced the "Advanced Operating Model" with legal disentanglement for the two divisions; dividend proposed EUR 2.10; share‑buyback tranches executed (first tranche approximately EUR 500 m) [10].

Investor stance moved to "resilient but normalising". Recognition of strong cash conversion and disciplined capital return was tempered by concerns about destocking, lower volumes and margin normalization. The story shifted toward quality/cash compounder with shorter‑term cyclical headwinds [10].

From 2022 highs the stock entered a material pullback and range as earnings normalized; buyback activity supported episodic rallies but the overall market priced a multiple reset [10].

Q1 2024 (reported May 2024)

Q1/2024 brought a shock: sales approximately EUR 4.00 bn (‑11% y/y), operating gross profit approximately EUR 984 m (‑6%), operating EBITA approximately EUR 260 m (‑24%); FCF approximately EUR 175 m. Management warned FY EBITA likely at the lower end of guidance and flagged pricing pressure and higher transport costs in some areas [23], [26], [19].

Near‑term disappointment surfaced; market turned cautious with short‑term "value‑trap" and execution watchlist narratives, while longer‑term transformation and removal of structural costs remained the anchor.

A short‑term downtrend and drawdown took hold with increased volatility and weaker technical momentum as macro and destocking fears dominated [23], [26].

FY 2024 (reported Mar 2025)

FY‑2024 delivered broadly acceptable results in a tough environment: sales approximately EUR 16.24 bn; operating gross profit approximately EUR 4.03 bn (approximately flat y/y); operating EBITA approximately EUR 1.10 bn (‑12.5%); free cash flow approximately EUR 892.6 m. A cost‑containment program delivered more than EUR 50 m savings; dividend maintained at EUR 2.10 [17], [18], [22].

The perception solidified around a company that can generate robust cash even when the top‑line cycles down. The narrative consolidated around capital returns, margin recovery potential and strategic separation of divisional responsibilities, with cautious optimism tempered by valuation discipline.

Stabilization and base‑building took shape through range trading with occasional rallies on positive cash‑flow headlines and M&A progress; the technical picture suggests consolidation after the 2022–2023 re‑rating and 2024 pullback [17], [18].

2025 (results cycle into early 2026)

The company showed resilience into 2025. Q1/2025 materials showed gross‑profit run‑rate data (e.g., gross profit approximately EUR 447 m per Q1 presentation) and full‑year 2025 operating gross profit cited at approximately EUR 3.8 bn in FY/Q4 commentary, with the company framing 2025 as a year of resilience amid continuing headwinds [28], [8].

Investors acknowledged operational resilience and continued cash focus, though expectations remained tempered on margin recovery. The story positioned itself as a mid‑cycle compounder that will need sustained top‑line recovery to re‑earn 2022 multiples.

A tactical recovery and moderate rally emerged from the 2024 base in response to improving volumes and cash visibility; the market remained cautious while watching sequential improvements [28], [8].

Mid‑2026 (as of 2026‑07‑11)

Ongoing execution of "Strategy to Win" continued with focus on divisional autonomy, M&A discipline and shareholder returns (dividend kept around EUR 2.10 in recent years; buybacks previously executed). The company operates in a mid‑cycle environment with mixed volume and pricing trends [10], [17], [18], [8].

The market view in mid‑2026 is that Brenntag is a structurally attractive, cash‑generative distributor whose valuation has reset from the 2022 peak. Investors trade it as a prudently returning‑capital compounder rather than a high‑growth cyclically‑levered story.

Consolidation and range trading characterize the technical picture with selective rallies. At the latest share price of 56.22, the pattern is consistent with a mid‑cycle base and consolidation phase where upside requires visible margin and volume re‑acceleration.